Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 3—March 2012


Community-associated Clostridium difficile Infections, Monroe County, New York, USA

Ghinwa DumyatiComments to Author , Vanessa Stevens, George E. Hannett, Angela D. Thompson, Cherie Long, Duncan MacCannell, and Brandi Limbago
Author affiliations: University of Rochester, Rochester, New York, USA (G. Dumyati, V. Stevens); State University of New York at Buffalo, Buffalo, New York, USA (V. Stevens); New York State Department of Health, Albany, New York, USA (G.E. Hannett); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.D. Thompson, C. Long, D. MacCannell, B. Limbago)

Main Article

Table 3

Possible exposures to medications and health care during 12 weeks before diagnosis of CA-CDI in 42 patients, Monroe County, New York, USA, March 1–August 31, 2008*

Exposure No. (%)
Antimicrobial drugs 32 (76)
Penicillins 12 (31)
Clindamycin 7 (18)
Cephalosporins 5 (13)
Quinolones 5 (13)
Macrolides 4 (10)
Sulfa 3 (8)
Metronidazole 2 (5)
H2 blockers 1 (2)
PPI 11 (26)
Health care†
None 5 (12)
Outpatient visit 35 (83)
Physician office 29 (69)
Dentist 13 (31)
Emergency department visit 6 (14)
Visited a hospital or LTCF 9 (21)
Health care–related job 2 (5)

*CA-CDI, community-associated Clostridium difficile infection; PPI, proton pump inhibitor; LTCF, long-term care facility.
†Multiple exposures could be reported in the 12 weeks before CDI.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO